跳至主要内容
临床试验/NCT06778226
NCT06778226已完成不适用

ThRombectomy In Mild Ischemic Stroke With a Visible Intracranial veSsel Occlusion

University of Miami3 个研究点 分布在 1 个国家目标入组 4,827 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
4,827
试验地点
3
主要终点
Modified Rankin Scale

研究概览

简要总结

The purpose of TRIMIS is to study how a medical procedure by the name of endovascular therapy compares to medical treatment alone in patients with mild stroke and a blood vessel occlusion in the brain

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Acute ischemic stroke in an adult patient (18 years of age or older).
  • •Onset (Last Seen Normal) time to treatment time <24 hours or unknown Last Seen Normal in whom Endovascular Therapy could be considered per local radiographic guidelines.
  • •Mild stroke defined as an NIH Stroke Scale ≤ 5 at the time of treatment decision.
  • •a. Patients with NIH Stroke Scale=0 can be included in the study if they have relevant abnormalities on neurological exam.
  • •An acute intracranial vessel occlusion (Intracranial Internal Carotid Artery terminus (T or L clot), Middle Cerebral Artery (M1, M2, M3/beyond), Anterior Cerebral Artery (A1, A2, A3), V4, Basilar, Posterior Cerebral Artery) defined by non-invasive acute imaging (Computed Tomography, angiography (Computed Tomography Angiography) or Magnetic Resonance angiography (MRA)) that is neurologically relevant to the presenting symptoms and signs.

排除标准

  • •Stroke symptoms due to another non-ischemic acute neurological condition such as seizure with Post-ictal Todd's paralysis or focal neurological signs due to severe hypo- or hyperglycemia.
  • •Hyperdensity on Non-contrast Computed Tomography consistent with intracranial hemorrhage. Any clinical suspicion of any intracranial hemorrhage even in the absence of visible blood on baseline brain imaging.
  • •Large acute stroke >1/3 Middle Cerebral Artery territory or Alberta Stroke Programme Early CT score (ASPECTS<6 or established frank hypodensity relevant to the presenting acute stroke already visible on baseline CT scan.
  • •Findings on acute CT or MRI to suggest that the
  • •Patient has a severe or fatal or disabling illness that will impact decision regarding acute reperfusion therapies.
  • •Clinical history, past imaging and clinical judgment suggest that the intracranial occlusion is chronic.
  • •Stroke occurred as an inpatient.
  • •Inclusion into any randomized control trials.

研究组 & 干预措施

Delayed Endovascular Therapy

Data previously collected from medical records of participants will be analyzed with the purpose of studying the efficiency of Delayed Endovascular Therapy. Length of the cohort is 6 years.

Medical Management

Data previously collected from medical records of participants will be analyzed with the purpose of studying the efficiency of Medical Management. Length of the cohort is 6 years.

Immediate Endovascular Therapy

Data previously collected from medical records will be analyzed with the purpose of studying the efficiency of Immediate Endovascular Therapy. Length of the cohort is 6 years.

结局指标

主要结局

Modified Rankin Scale

时间窗: 90 Days

Scores range from 0-6. (0 = normal, 6 = dead).

次要结局

  • Symptomatic Intracerebral Hemorrhage (sICH)(48 hours)
  • Change in National Institute of Health Stroke Scale (NIHSS)(24 hours, 7 days)
  • Modified Rankin Scale(7 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Negar Asdaghi

Associate Professor of Neurology

University of Miami

研究点 (3)

Loading locations...

相似试验